dc.contributor.author |
Jana, S S |
|
dc.contributor.author |
Bharali, D J |
|
dc.contributor.author |
Mani, Prashant |
|
dc.contributor.author |
Maitra, Amarnath |
|
dc.contributor.author |
Gupta, C M |
|
dc.contributor.author |
Sarkar, D P |
|
dc.date.accessioned |
2008-10-23T20:54:15Z |
|
dc.date.available |
2008-10-23T20:54:15Z |
|
dc.date.issued |
2002 |
|
dc.identifier.citation |
FEBS Letters 515, 184- 189 |
en |
dc.identifier.uri |
http://hdl.handle.net/123456789/206 |
|
dc.description.abstract |
Hydrogel nanoparticles of cross-linked polyvinylpyrrolidone (PVP-NP) (35-50 nm in diameter) containing fluoresceinated dextran (FITC-Dx) were encapsulated in reconstituted Sendai viral envelopes containing only the fusion (F) protien (F- virosomes). Incubtion of these loaded F- virosmes with human hepatoblastoma cells (HepG2) in culture cytoplasm, as inferred froom the ability of cells tointernalize FITC-Dx loaded PVP-NP(PVP-NP) in the presence of azide (an inhibitor of the endocytotic process). Introduction of PVP-NP into the HelpG2 cells wasw assured by selctive accumulation of FITC fluorescence in the cytosolic compartment. The structural integrity of the internalzed PVP-NP was also confirmed by fluorescence microscopy and ultracentrifugation analysis. The potential usefulness of PVP-NP -mediated cytosolic release of water soluble drugs boyh in vitro and in vivo has been established for the first time. |
en |
dc.format.extent |
3058853 bytes |
|
dc.format.mimetype |
application/pdf |
|
dc.language.iso |
en |
en |
dc.subject |
Hydrogel nanoparticle |
en |
dc.subject |
Sendai virus |
en |
dc.subject |
Virosome |
en |
dc.subject |
Drug delivery |
en |
dc.subject |
Targeted cytosolic delivery |
en |
dc.subject |
Controlled release |
en |
dc.title |
Targeted cytosolic delivery of hydrogel nanoparticles into HepG2 cells through engineered Sendai viral envelopes |
en |
dc.type |
Article |
en |